Royal baby rules and travel chaos on today’s front pages

Travel misery and pledges from new Prime Minister Boris Johnson make the headlines on Saturday. The Times reports that Mr Johnson is to target Labour’s pro-Brexit heartlands and promise to spend more than £2 billion on deprived towns. Sorry, this content isn’t available on your device. The Financial Times leads …

Read More »

Clovis Oncology (NASDAQ:CLVS) Given “Buy” Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Clovis Oncology (NASDAQ:CLVS) in a research report released on Wednesday, July 3rd, Stock Target Advisor reports. “Our $36 price target is derived from a sum-of-the-parts analysis based on probability-adjusted revenue forecasts for Rubraca in ovarian cancer combination and prostate cancer indications, …

Read More »